That
"Which makes one question the pilot plant being built by Jan 2015"
is no longer a question now.
And never really has been a question, as dilution has never been the plan to pay for the MVTG ERC plants.
That is why, and how MVTG held the OS share structure so low for so many years, by not using dilution and shares to pay for the big items like the ERC plants.
They also held the MVTG cash burn costs down to record low levels compared to every other high tech comparable stock I have ever tracked, by not paying huge bloated salaries and by tapping Canadian government funding in multiple grants. Grants available in multiple programs that have covered huge costs for the MVTG staff, R&D at UBC University and travel and promotion of the MVTG ERC and MRFC technologies world wide, which is all why shares of MVTG are up nearly 1000% (Including the ones I bought that no one else wanted at .01 and .02 and .06 and .12 and .21 and .30 because they feared dilution and drank the hemlock....., and so on) from the recent 52 week low.
It is also one of the many reasons MVTG shares will go much higher, again, than the current prices, as MVTG is still an easy 10 bagger to go here with all the news coming.
For instance MVTG has only a fraction of the market cap of most Biotech stocks that are much farther away from turning profitable than MVTG is.
Take any biotech stock today that has no sales at all (MVTG actually has revenue already, WOW!!), that just has a cash burn rate that is 10 to 25 times the cash burn rate of MVTG, and compare the target dates for commercial operation, completion of phase 1-3 drug trials and FDA approvals after an NDA (New Drug App..) that all combined takes 5-10 years from phase 1, some with out even an issued patent yet, that have 500 Mil to 1 billion dollar market caps, and then look at MVTG which has 6 issued patents, working ERC and MRFC systems, and is just a short effort away from closing huge licensing $$$$ Revenue deals with multiple mega billion dollar firms including Alstom (who is already funding some MVTG operations with revenue), Lafarge, and now the Bavarian brewery, and it is clear that MVTG is way undervalued and a screaming buy again.
